Study: Callender 2025, Journal of Clinical and Aesthetic Dermatology

Efficacy and Safety of Fixed-dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants with Moderate to Severe Acne

Citation

Callender VD, Alexis AF, Bhatia N, Harper JC et al (2025). Journal of Clinical and Aesthetic Dermatology. PubMed id 40256338.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Dark marks after acne (post-inflammatory hyperpigmentation) Tier A thin

    B 156 Black participants (14% of 1,115) pooled from four industry trials in acne (n=156)

    Post hoc subgroup analysis of a clindamycin, adapalene and benzoyl peroxide triple gel against vehicle, 12 weeks.

    Acne treatment success was 32.0% against 18.3% on vehicle (P=0.07). Inflammatory and noninflammatory lesions fell more with the gel, and hyperpigmentation scores stayed at or below baseline. The authors state the studies were not powered for Black participants, so P values are informative only.

    As recorded in this card: Callender VD, Alexis AF, Bhatia N, Harper JC et al (2025), Journal of Clinical and Aesthetic Dermatology, [primary]

    Note: Industry-sponsored trials (the gel is a branded product), post hoc subgroup, hyperpigmentation was a safety score, not the main outcome. Treats acne, not marks.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.